The protective effects of ligustrazine on ischemia-reperfusion and DPPH free radical-induced myocardial injury in isolated rat hearts

Planta Medica

Volumn 70, Issue 9, 2004, Pages 818-822

  Zhou, Yuan ^a   Hu, Chang Ping ^b   Deng, Pan Yue ^b   Deng, Han Wu ^b   Li, Yuan Jian ^b  

^a HUNAN NORMAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

1,1 diphenyl 2 picrylhydrazyl; Apiaceae; Ligusticum wallichii; Ligustrazine; Myocardial ischemia reperfusion injury; Rat isolated heart; Tumor necrosis factor alpha

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CREATINE KINASE; FREE RADICAL; TETRAMETHYLPYRAZINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME RELEASE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART RATE; ISCHEMIC HEART DISEASE; ISOLATED HEART; LIGUSTICUM; LIGUSTICUM WALLICHII; NONHUMAN; RAT;

ANIMALS; CARDIOTONIC AGENTS; LIGUSTICUM; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PHYTOTHERAPY; PICRATES; PLANT EXTRACTS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; APIACEAE; LIGUSTICUM;

EID: 5444261804     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-827229     Document Type: Article

References (13)

1. Marban E, Koretsune Y, Corretti M, Chacko VP, Kusuoke H. Calcium and its role in myocardial cell injury during ischemia reperfusion. Circulation 1989; 80: IV17-22
2. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992; 20: 118-27
3. Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther 2002; 94: 123-35
4. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia reperfusion. J Am Coll Cardiol 1996; 28: 247-52
5. Li YJ, Peng J. The cardioprotection of calcitonin gene-related peptide-mediated preconditioning. Eur J Pharmacol 2002; 442: 173-7
6. 2+ channel? J Cardiovasc Pharmacol 1990; 15: 157-62
7. Jiang DJ, Hu GY, Jiang JL, Xiang HL, Deng HW, Li YJ. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorg Med Chem 2003; 11: 5171-7
8. Hu CP, Xiao L, Deng HW, Li YJ. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med 2002; 68: 705-9
9. Ferrari R, Visioli O. Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs 1991; 42: 14-26
10. Chen JB, Huang CX, Tang QJ, Li JJ, Xu JL, Li GS. Electrophysiological effect of tetramethylpyrazine on ventricular myocardium. Acta Acad Med Hubei 1999; 20: 111-3
11. Jin ZQ, Chen X. A simple reproducible model of free radical-injury isolated heart induced by 1,1-diphenyl-2-picryl-hydrazyl (DPPH). J Pharmacol Toxicol Method 1998; 39: 63-70
12. Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998; 98: 699-710
13. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL et al. Tumor necrosis factor-alpha induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac myocytes. J Clin Invest 1996; 98: 2854-65